208 related articles for article (PubMed ID: 9808519)
1. hTERT is a critical determinant of telomerase activity in renal-cell carcinoma.
Kanaya T; Kyo S; Takakura M; Ito H; Namiki M; Inoue M
Int J Cancer; 1998 Nov; 78(5):539-43. PubMed ID: 9808519
[TBL] [Abstract][Full Text] [Related]
2. Human telomerase reverse transcriptase as a critical determinant of telomerase activity in normal and malignant endometrial tissues.
Kyo S; Kanaya T; Takakura M; Tanaka M; Inoue M
Int J Cancer; 1999 Jan; 80(1):60-3. PubMed ID: 9935231
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of full-length telomerase reverse transcriptase mRNA and telomerase activity between normal and malignant renal tissues.
Fan Y; Liu Z; Fang X; Ge Z; Ge N; Jia Y; Sun P; Lou F; Björkholm M; Gruber A; Ekman P; Xu D
Clin Cancer Res; 2005 Jun; 11(12):4331-7. PubMed ID: 15958614
[TBL] [Abstract][Full Text] [Related]
4. Expression of human telomerase subunits and correlation with telomerase activity in urothelial cancer.
Ito H; Kyo S; Kanaya T; Takakura M; Inoue M; Namiki M
Clin Cancer Res; 1998 Jul; 4(7):1603-8. PubMed ID: 9676833
[TBL] [Abstract][Full Text] [Related]
5. Expression of human telomerase subunits in ovarian malignant, borderline and benign tumors.
Kyo S; Kanaya T; Takakura M; Tanaka M; Yamashita A; Inoue H; Inoue M
Int J Cancer; 1999 Mar; 80(6):804-9. PubMed ID: 10074910
[TBL] [Abstract][Full Text] [Related]
6. Expression of the human telomerase reverse transcriptase is not related to telomerase activity in normal and malignant renal tissue.
Rohde V; Sattler HP; Bund T; Bonkhoff H; Fixemer T; Bachmann C; Lensch R; Unteregger G; Stoeckle M; Wullich B
Clin Cancer Res; 2000 Dec; 6(12):4803-9. PubMed ID: 11156238
[TBL] [Abstract][Full Text] [Related]
7. hTERT expression in sporadic renal cell carcinomas.
Paradis V; Bièche I; Dargère D; Bonvoust F; Ferlicot S; Olivi M; Lagha NB; Blanchet P; Benoît G; Vidaud M; Bedossa P
J Pathol; 2001 Sep; 195(2):209-17. PubMed ID: 11592100
[TBL] [Abstract][Full Text] [Related]
8. Expression of telomerase genes in thyroid carcinoma.
Hoang-Vu C; Boltze C; Gimm O; Poremba C; Dockhorn-Dworniczak B; Köhrle J; Rath FW; Dralle H
Int J Oncol; 2002 Aug; 21(2):265-72. PubMed ID: 12118320
[TBL] [Abstract][Full Text] [Related]
9. Telomerase activity and expression of human telomerase catalytic subunit gene in esophageal tissues.
Tominaga T; Kashimura H; Suzuki K; Nakahara A; Tanaka N; Noguchi M; Itabashi M; Ohkawa J
J Gastroenterol; 2002; 37(6):418-27. PubMed ID: 12108675
[TBL] [Abstract][Full Text] [Related]
10. Telomerase activity and expression of telomerase genes in squamous dysplasia and squamous cell carcinoma of the esophagus.
Yu HP; Xu SQ; Lu WH; Li YY; Li F; Wang XL; Su YH
J Surg Oncol; 2004 May; 86(2):99-104. PubMed ID: 15112252
[TBL] [Abstract][Full Text] [Related]
11. Quantitative analysis of telomerase activity and telomerase reverse transcriptase expression in renal cell carcinoma.
Hara T; Noma T; Yamashiro Y; Naito K; Nakazawa A
Urol Res; 2001 Feb; 29(1):1-6. PubMed ID: 11310208
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of proliferation and induction of apoptosis in human renal carcinoma cells by anti-telomerase small interfering RNAs.
Zheng JN; Sun YF; Pei DS; Liu JJ; Chen JC; Li W; Sun XQ; Shi QD; Han RF; Ma TX
Acta Biochim Biophys Sin (Shanghai); 2006 Jul; 38(7):500-6. PubMed ID: 16820866
[TBL] [Abstract][Full Text] [Related]
13. Detection of telomerase status by semiquantitative and in situ assays, and by real-time reverse transcription-polymerase chain reaction (telomerase reverse transcriptase) assay in bladder carcinomas.
Longchampt E; Lebret T; Molinie V; Bieche I; Botto H; Lidereau R
BJU Int; 2003 Apr; 91(6):567-72. PubMed ID: 12656916
[TBL] [Abstract][Full Text] [Related]
14. Telomerase activity and expression of telomerase reverse transcriptase correlated with cell proliferation in meningiomas and malignant brain tumors in vivo.
Cabuy E; de Ridder L
Virchows Arch; 2001 Aug; 439(2):176-84. PubMed ID: 11561758
[TBL] [Abstract][Full Text] [Related]
15. Comparison of human telomerase reverse transcriptase messenger RNA and telomerase activity as urine markers for diagnosis of bladder carcinoma.
Bialkowska-Hobrzanska H; Bowles L; Bukala B; Joseph MG; Fletcher R; Razvi H
Mol Diagn; 2000 Dec; 5(4):267-77. PubMed ID: 11172490
[TBL] [Abstract][Full Text] [Related]
16. Demonstration of human telomerase reverse transcriptase in human colorectal carcinomas by in situ hybridization.
Kammori M; Kanauchi H; Nakamura K; Kawahara M; Weber TK; Mafune K; Kaminishi M; Takubo K
Int J Oncol; 2002 Jan; 20(1):15-21. PubMed ID: 11743637
[TBL] [Abstract][Full Text] [Related]
17. Role of human telomerase reverse transcriptase and telomeric-repeat binding factor proteins 1 and 2 in human hematopoietic cells.
Yamada K; Yajima T; Yagihashi A; Kobayashi D; Koyanagi Y; Asanuma K; Yamada M; Moriai R; Kameshima H; Watanabe N
Jpn J Cancer Res; 2000 Dec; 91(12):1278-84. PubMed ID: 11123427
[TBL] [Abstract][Full Text] [Related]
18. hTERT mRNA expression correlates with telomerase activity in human breast cancer.
Kirkpatrick KL; Clark G; Ghilchick M; Newbold RF; Mokbel K
Eur J Surg Oncol; 2003 May; 29(4):321-6. PubMed ID: 12711283
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of hTERT expression by MAP kinase inhibitor induces cell death in renal cell carcinoma.
Pal D; Sharma U; Singh SK; Kakkar N; Prasad R
Urol Oncol; 2017 Jun; 35(6):401-408. PubMed ID: 28215740
[TBL] [Abstract][Full Text] [Related]
20. Correlation between expression of human telomerase subunits and telomerase activity in esophageal squamous cell carcinoma.
Li C; Wu MY; Liang YR; Wu XY
World J Gastroenterol; 2003 Nov; 9(11):2395-9. PubMed ID: 14606063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
